Volume 20, Number 1—January 2014
CME ACTIVITY - Research
Raw Milk Consumption among Patients with Non–Outbreak-related Enteric Infections, Minnesota, USA, 2001–2010
Trisha J. Robinson
, Joni M. Scheftel, and Kirk E. Smith
, Joni M. Scheftel, and Kirk E. Smith
Table 1
Demographic characteristics of patients with domestically acquired, sporadic enteric infections, Minnesota, 2001–2010
| Pathogen |
Patients reporting raw milk consumption |
Patients denying raw milk consumption |
|||||
| No. patients |
Median age, y (range) |
Male, % |
No. patients |
Median age, y (range) |
Male, % |
||
| Campylobacter spp. |
407 |
18 (<1–92)* |
63.9* |
6,340 |
33 (<1–96) |
56.9 |
|
| Cryptosporidium spp. |
53 |
8 (1–74)* |
52.8 |
1,689 |
21 (<1–101) |
45.6 |
|
| Escherichia coli O157 |
19 |
5 (<1–63)* |
63.2 |
1,050 |
16 (<1–92) |
46.3 |
|
| Non-O157 Shiga toxin–producing E. coli |
12 |
4 (1–61) |
66.7 |
342 |
18 (<1–88) |
46.3 |
|
| Salmonella spp. |
39 |
16 (1–78)* |
59.0 |
4,388 |
28 (<1–98) |
46.6 |
|
| Total | 530 | 17 (<1–92)* | 62.6* | 13,809 | 29 (<1–101) | 51.3 | |
*Significantly different (p<0.05) from persons who denied raw milk consumption.
Page created: January 03, 2014
Page updated: January 03, 2014
Page reviewed: January 03, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.